ESR1 and breast carcinoma: Additionally, MYSM1 expression has been identified in various tumor cells, including castration-resistant prostate cancer (CRPC) cells [8], colorectal cancer (CRC) cells [9], melanoma cells [10], ERα-positive breast cancer (BC) cells [11], and triple-negative breast cancer (TNBC) cells [12].